Octarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…
Read moreOskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…
Read moreIreland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…
Read moreTHE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…
Read moreMercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…
Read moreThe good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…
Read more
